Immediate Impact
49 standout
Citing Papers
Oxidative Stress and Redox Imbalance: Common Mechanisms in Cancer Stem Cells and Neurodegenerative Diseases
2025 Standout
Prunin: An Emerging Anticancer Flavonoid
2025 Standout
Works of Michael Boice being referenced
A phase IB trial of 24-hour intravenous PX-12, a thioredoxin-1 inhibitor, in patients with advanced gastrointestinal cancers
2012
108 POSTER Screening Plasma Thioredoxin-1 (Trx-1) to potentially guide clinical development of the Trx-1 Inhibitor PX-12
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Boice | 172 | 131 | 11 | 37 | 6 | 234 | |
| Christy M. Gearheart | 182 | 49 | 5 | 16 | 9 | 272 | |
| Candace J. Poole | 228 | 47 | 4 | 13 | 10 | 285 | |
| Annelynn Wallaert | 190 | 139 | 2 | 68 | 9 | 266 | |
| Séverine Landais | 216 | 174 | 2 | 10 | 9 | 275 | |
| Astrid Novosel | 98 | 82 | 42 | 5 | 159 | ||
| Asuka Hira | 233 | 74 | 1 | 16 | 9 | 285 | |
| Amaia Arruabarrena-Aristorena | 203 | 69 | 17 | 7 | 263 | ||
| Junyi Yin | 146 | 89 | 3 | 10 | 8 | 245 | |
| Hélène Lelièvre | 177 | 56 | 3 | 7 | 9 | 249 | |
| Claudie Bosc | 160 | 101 | 4 | 6 | 6 | 251 |
All Works
Loading papers...